For the next two weeks or so, my article “Targeting TDP-43 in ALS: Regulatory hurdles, trial design deficiencies, and the causal evidence gap for CTx1000″ is available for reading and downloading for free at this link:Â https://www.sciencedirect.com/science/article/pii/S1359644626001571?dgcid=author After that, the article will go behind a journal paywall for a year or more. The therapeutic landscape […]
Archive for August 17th, 2026
Targeting TDP-43 in ALS: Regulatory hurdles, trial design deficiencies, and the causal evidence gap for CTx1000
Posted by Michael A. S. Guth on August 17th, 2026



Posted in